As of March 31, 2026, ALS Ltd. carries a market capitalization of 10.56B, placing it among publicly traded companies globally. Its enterprise value stands at 11.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.56B |
| Enterprise Value | 11.98B |
ALS Ltd.'s next confirmed earnings release is scheduled for November 23, 2026.
| Earnings Date | 11/23/2026 |
As of March 31, 2026, ALS Ltd. has 507.54M shares outstanding.
| Shares Outstanding | 507.54M |
As of March 31, 2026, ALS Ltd. trades at a trailing price-to-earnings ratio of 31.65. The price-to-sales ratio is 3.04, and the price-to-book ratio stands at 6.21.
| PE Ratio | 31.65 |
| PS Ratio | 3.04 |
| PB Ratio | 6.21 |
| P/TBV Ratio | 117.95 |
As of March 31, 2026, ALS Ltd. trades at an EV/EBITDA multiple of 15.53 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.61 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 23.13 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 11.98B versus a market cap of 10.56B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 3.61 |
| EV / EBITDA | 15.53 |
| EV / EBIT | 23.13 |
As of March 31, 2026, ALS Ltd. maintains a current ratio of 1.47, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 92.19, indicating elevated leverage, while an interest coverage ratio of 12.44 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.47 |
| Quick Ratio | 1.15 |
| Debt / Equity | 92.19 |
| Debt / EBITDA | 2.04 |
| Interest Coverage | 12.44 |
Over the twelve months ended March 31, 2026, ALS Ltd. posted a return on equity (ROE) of 21.39, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 10.99 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.00, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.79, useful for judging operating efficiency across full business cycles. The company generates approximately 142,237.17 in revenue per employee across its workforce of 23,342.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.66 indicates how many times ALS Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 21.39 |
| Return on Assets (ROA) | 8.00 |
| Return on Invested Capital (ROIC) | 10.99 |
| Return on Capital Employed (ROCE) | 10.79 |
| Revenue Per Employee | 142,237.17 |
| Employee Count | 23,342.00 |
| Inventory Turnover | 2.66 |
Over the twelve months ended March 31, 2026, ALS Ltd. recorded 133.10M in income tax expense. That works out to an effective tax rate of 29.27, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 454.70M, leaving 318.70M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 133.10M |
| Effective Tax Rate | 29.27 |
As of the close on October 22, 2026, ALS Ltd.'s stock has declined approximately 6.99% over the past 52 weeks. The 50-day moving average sits at 21.25, while the 200-day moving average is 22.41.
| 52-Week Price Change | -6.99% |
| 50-Day Moving Average | 21.25 |
| 200-Day Moving Average | 22.41 |
Over the twelve months ended March 31, 2026, ALS Ltd. generated 3.32B in revenue and converted that into 318.70M in net income, yielding earnings per share of 0.64. EBITDA reached 771.50M, while operating income came in at 528.20M.
| Revenue | 3.32B |
| Gross Profit | 2.98B |
| Operating Income | 528.20M |
| Pretax Income | 454.70M |
| Net Income | 318.70M |
| EBITDA | 771.50M |
| EBIT | 518.10M |
| Earnings Per Share (EPS) | 0.64 |
As of March 31, 2026, ALS Ltd. holds 149.70M in cash and equivalents against 1.57B in total debt, resulting in a net debt position of 1.07B. Total book value stands at 1.70B, with working capital of 313.90M providing operational flexibility.
| Cash & Cash Equivalents | 149.70M |
| Total Debt | 1.57B |
| Net Debt | 1.07B |
| Equity (Book Value) | 1.70B |
| Book Value Per Share | 3.35 |
| Working Capital | 313.90M |
These figures cover the twelve months ended March 31, 2026.
| Capital Expenditures | -263.00M |
Over the twelve months ended March 31, 2026, ALS Ltd. posted a gross margin of 89.73, reflecting its pricing power and cost economics. The operating margin of 15.91 and net profit margin of 9.60 provide insight into operational efficiency.
| Gross Margin | 89.73 |
| Operating Margin | 15.91 |
| Pretax Margin | 13.70 |
| Profit Margin | 9.60 |
| EBITDA Margin | 23.24 |
Over the twelve months ended March 31, 2026, ALS Ltd. paid dividends of 0.40 per share. The dividend payout ratio of 59.66 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 3.21, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to ALS Ltd. shareholders.
| Dividend Per Share | 0.40 |
| Payout Ratio | 59.66 |
| Shareholder Yield | 3.21 |
ALS Ltd.'s most recent stock split took place on November 30, 2015 with a 227:241 split ratio.
| Last Split Date | 11/30/2015 |
| Split Ratio | 227:241 |
As of March 31, 2026, ALS Ltd. has an Altman Z-Score of 5.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.30 |
Already premium?